Travaux scientifiques
Uzm. Dr. Aysun Arslantaş Erken
11 publications. La source de l’information est indiquée à côté de chaque publication.
-
Clinical–Pathologic Response Discordance After Neoadjuvant Therapy in Rectal Cancer and Its Prognostic Implications
Asia-Pacific Journal of Clinical Oncology, 2026
DOI 10.1111/ajco.70119 PMID 42056758 Source : ORCID
-
Real‐World Outcomes of Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiotherapy in Stage II–III Locally Advanced Rectal Cancer: A Comparative Cohort Study
Asia-Pacific Journal of Clinical Oncology, 2026
DOI 10.1111/ajco.70118 PMID 42015370 Source : ORCID
-
Kemoterapi
Akademisyen Kitabevi eBooks, 2026
DOI 10.37609/akya.4045.c4306 Source : ORCID
-
Radyoterapi
Akademisyen Kitabevi eBooks, 2026
DOI 10.37609/akya.4045.c4305 Source : ORCID
-
Hasta ve Yakınları için Onkoloji Rehberi
Akademisyen Kitabevi eBooks, 2026
DOI 10.37609/akya.4045 Source : OpenAlex
-
Stereotactic radiotherapy for adrenal metastases: a multi-institutional review of patient characteristics and outcomes. Turkish Society for Radiation Oncology SBRT Group Study (TROD SBRT 10-004)
Oncology Research and Treatment, 2022
DOI 10.1159/000527052 PMID 36116432 5 citations (Europe PMC) Source : ORCID
-
Organ At Risk (OAR) Data on Clinical Toxicity in The Treatment of Bulky Adrenal Metastases With Stereotactic Ablative Radiotherapy (SABR)
Research Square, 2022
DOI 10.21203/rs.3.rs-1356246/v1 Texte intégral en libre accèsSource : OpenAlex
-
PO-1440 Multi-institutional review of SBRT for adrenal metastasis: Turkish Radiation Oncology Society Study
Radiotherapy and Oncology, 2022
DOI 10.1016/s0167-8140(22)03404-1 Source : OpenAlex
-
Organ At Risk (OAR) Data on Clinical Toxicity in The Treatment of Bulky Adrenal Metastases With Stereotactic Ablative Radiotherapy (SABR)
Research Square, 2022
DOI 10.21203/rs.3.rs-1356246/v2 Texte intégral en libre accèsSource : OpenAlex
-
Extreme hypofractionated radiosurgery in recurrent inoperable High-Grade Ultra-Large gliomas
International Journal of Radiation Research, 2022
Source : ORCID
-
The contributory role of multidisciplinary meetings in the diagnosis and treatment of breast cancer
Journal of B U on, 2021
Source : ORCID